These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 19395437)
1. False-negative results in point-of-care qualitative human chorionic gonadotropin (hCG) devices due to excess hCGbeta core fragment. Gronowski AM; Cervinski M; Stenman UH; Woodworth A; Ashby L; Scott MG Clin Chem; 2009 Jul; 55(7):1389-94. PubMed ID: 19395437 [TBL] [Abstract][Full Text] [Related]
2. Using a simulation model to assess risk of false negative point-of-care urinary human chorionic gonadotropin device results due to high-dose hook interference. Milhorn D; Korpi-Steiner N Clin Biochem; 2015 Feb; 48(3):99-104. PubMed ID: 25448030 [TBL] [Abstract][Full Text] [Related]
3. Falsely decreased human chorionic gonadotropin (hCG) results due to increased concentrations of the free beta subunit and the beta core fragment in quantitative hCG assays. Grenache DG; Greene DN; Dighe AS; Fantz CR; Hoefner D; McCudden C; Sokoll L; Wiley CL; Gronowski AM Clin Chem; 2010 Dec; 56(12):1839-44. PubMed ID: 20930131 [TBL] [Abstract][Full Text] [Related]
4. Screening method to evaluate point-of-care human chorionic gonadotropin (hCG) devices for susceptibility to the hook effect by hCG β core fragment: evaluation of 11 devices. Nerenz RD; Song H; Gronowski AM Clin Chem; 2014 Apr; 60(4):667-74. PubMed ID: 24463559 [TBL] [Abstract][Full Text] [Related]
5. Analytical sensitivity of four commonly used hCG point of care devices. Kamer SM; Foley KF; Schmidt RL; Greene DN Clin Biochem; 2015 Apr; 48(6):448-52. PubMed ID: 25549977 [TBL] [Abstract][Full Text] [Related]
7. Limitations in qualitative point of care hCG tests for detecting early pregnancy. Greene DN; Schmidt RL; Kamer SM; Grenache DG; Hoke C; Lorey TS Clin Chim Acta; 2013 Jan; 415():317-21. PubMed ID: 23159297 [TBL] [Abstract][Full Text] [Related]
8. Urinary human chorionic gonadotropin isoform concentrations in doping control samples. Butch AW; Woldemariam GA Drug Test Anal; 2016 Nov; 8(11-12):1147-1151. PubMed ID: 27594536 [TBL] [Abstract][Full Text] [Related]
9. Qualitative point-of-care and over-the-counter urine hCG devices differentially detect the hCG variants of early pregnancy. Cervinski MA; Lockwood CM; Ferguson AM; Odem RR; Stenman UH; Alfthan H; Grenache DG; Gronowski AM Clin Chim Acta; 2009 Aug; 406(1-2):81-5. PubMed ID: 19477170 [TBL] [Abstract][Full Text] [Related]
10. False-negative results from point-of-care qualitative human chorionic gonadotropin (hCG) devices caused by excess hCGbeta core fragment vary with device lot number. Gronowski AM; Powers M; Stenman UH; Ashby L; Scott MG Clin Chem; 2009 Oct; 55(10):1885-6. PubMed ID: 19679628 [No Abstract] [Full Text] [Related]
11. Point-of-care and over-the-counter qualitative human chorionic gonadotropin (hCG) devices remain susceptible to false-negative results caused by excess hCG β core fragment. Nerenz RD; Gronowski AM Clin Chem; 2013 Nov; 59(11):1672-4. PubMed ID: 23985957 [No Abstract] [Full Text] [Related]
12. Urinary Tract Infection With Gram-Positive Bacteria Does Not Cause False-Positive Results with the Urine-Based Human Chorionic Gonadotropic Point-of-Care Assay. Mitchell KF; Burnham CD; Gronowski AM J Appl Lab Med; 2020 Sep; 5(5):987-992. PubMed ID: 32761095 [TBL] [Abstract][Full Text] [Related]
13. Importance of the detection method for intact dimeric human chorionic gonadotropin without interference with the free human chorionic gonadotropin beta subunit for pregnancy exclusion before liver transplantation in a woman with cholangiocarcinoma. Massart C; Lucas C; Rioux-Leclercq N; Fergelot P; Pouvreau-Quillien V; Volatron AC Clin Chem Lab Med; 2005; 43(8):886-9. PubMed ID: 16217885 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of a semi-quantitative pregnancy device for susceptibility to interference caused by hCGβcf. Nerenz RD; Butch AW; Ashby L; Woldemariam GA; Gronowski AM Clin Biochem; 2015 Aug; 48(12):815-7. PubMed ID: 25916816 [TBL] [Abstract][Full Text] [Related]
15. Significance of pregnancy test false negative results due to elevated levels of β-core fragment hCG. Johnson S; Eapen S; Smith P; Warren G; Zinaman M J Immunoassay Immunochem; 2017; 38(4):449-455. PubMed ID: 28521601 [TBL] [Abstract][Full Text] [Related]
16. False-Negative Urine Human Chorionic Gonadotropin Testing in the Clinical Laboratory. Herskovits AZ; Chen Y; Latifi N; Ta RM; Kriegel G Lab Med; 2020 Jan; 51(1):86-93. PubMed ID: 31245816 [TBL] [Abstract][Full Text] [Related]
17. Enzyme Immunoassay of Urinary β-Core Fragment of Human Chorionic Gonadotropin as a Tumor Marker for Ovarian Cancer. Nishimura R; Koizumi T; Das H; Takemori M; Hasegawa K Methods Mol Med; 2001; 39():135-41. PubMed ID: 21340764 [TBL] [Abstract][Full Text] [Related]
18. Determination of human chorionic gonadotropin. Stenman UH; Alfthan H Best Pract Res Clin Endocrinol Metab; 2013 Dec; 27(6):783-93. PubMed ID: 24275190 [TBL] [Abstract][Full Text] [Related]
19. Immunoextraction-tandem mass spectrometry method for measuring intact human chorionic gonadotropin, free β-subunit, and β-subunit core fragment in urine. Woldemariam GA; Butch AW Clin Chem; 2014 Aug; 60(8):1089-97. PubMed ID: 24899693 [TBL] [Abstract][Full Text] [Related]
20. Human chorionic gonadotropin in pregnancy diagnostics. Montagnana M; Trenti T; Aloe R; Cervellin G; Lippi G Clin Chim Acta; 2011 Aug; 412(17-18):1515-20. PubMed ID: 21635878 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]